Pinnacle Wealth Planning Services Inc. Invests $212,000 in Integer Holdings Corporation $ITGR

Pinnacle Wealth Planning Services Inc. acquired a new stake in Integer Holdings Corporation (NYSE:ITGR) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 1,726 shares of the medical equipment provider’s stock, valued at approximately $212,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of ITGR. Geode Capital Management LLC lifted its stake in Integer by 3.9% in the 2nd quarter. Geode Capital Management LLC now owns 819,089 shares of the medical equipment provider’s stock worth $100,736,000 after purchasing an additional 31,026 shares in the last quarter. Congress Asset Management Co. increased its holdings in shares of Integer by 1.6% in the second quarter. Congress Asset Management Co. now owns 530,807 shares of the medical equipment provider’s stock worth $65,273,000 after purchasing an additional 8,151 shares during the period. Aberdeen Group plc raised its position in shares of Integer by 38.5% in the second quarter. Aberdeen Group plc now owns 319,229 shares of the medical equipment provider’s stock worth $39,256,000 after buying an additional 88,784 shares in the last quarter. Raymond James Financial Inc. boosted its stake in Integer by 6.9% during the first quarter. Raymond James Financial Inc. now owns 307,141 shares of the medical equipment provider’s stock valued at $36,245,000 after buying an additional 19,839 shares during the period. Finally, Envestnet Asset Management Inc. grew its position in Integer by 0.3% during the second quarter. Envestnet Asset Management Inc. now owns 239,482 shares of the medical equipment provider’s stock worth $29,449,000 after buying an additional 772 shares in the last quarter. Institutional investors own 99.29% of the company’s stock.

Integer Trading Down 0.2%

Shares of ITGR stock opened at $67.60 on Thursday. The business has a 50-day moving average of $89.48 and a 200 day moving average of $105.88. The company has a debt-to-equity ratio of 0.70, a current ratio of 3.71 and a quick ratio of 2.45. Integer Holdings Corporation has a 1-year low of $62.00 and a 1-year high of $146.36. The stock has a market capitalization of $2.37 billion, a PE ratio of 28.28, a P/E/G ratio of 0.60 and a beta of 0.95.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, October 23rd. The medical equipment provider reported $1.79 EPS for the quarter, topping analysts’ consensus estimates of $1.68 by $0.11. Integer had a return on equity of 12.84% and a net margin of 4.75%.The firm’s revenue was up 8.4% compared to the same quarter last year. During the same period in the previous year, the company posted $1.43 EPS. Integer has set its FY 2025 guidance at 6.290-6.430 EPS. As a group, sell-side analysts anticipate that Integer Holdings Corporation will post 6.01 earnings per share for the current year.

Integer declared that its Board of Directors has approved a share repurchase plan on Tuesday, November 4th that allows the company to buyback $200.00 million in shares. This buyback authorization allows the medical equipment provider to buy up to 8.3% of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s leadership believes its shares are undervalued.

Wall Street Analysts Forecast Growth

ITGR has been the subject of a number of research analyst reports. Wells Fargo & Company reiterated an “equal weight” rating and set a $80.00 price target (down previously from $132.00) on shares of Integer in a research report on Friday, October 24th. Argus downgraded shares of Integer from a “buy” rating to a “hold” rating in a research note on Friday, October 24th. Citigroup cut their price target on shares of Integer from $77.00 to $69.00 and set a “neutral” rating for the company in a research note on Monday, November 3rd. Raymond James Financial restated an “outperform” rating and set a $95.00 price objective (down previously from $143.00) on shares of Integer in a research report on Friday, October 24th. Finally, Benchmark reaffirmed a “hold” rating on shares of Integer in a report on Friday, October 24th. Four analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $96.75.

Insider Activity

In other news, CEO Payman Khales purchased 3,127 shares of the business’s stock in a transaction on Thursday, October 30th. The shares were acquired at an average price of $64.94 per share, with a total value of $203,067.38. Following the acquisition, the chief executive officer directly owned 22,865 shares in the company, valued at approximately $1,484,853.10. The trade was a 15.84% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Diron Smith acquired 1,116 shares of the stock in a transaction dated Friday, November 7th. The shares were purchased at an average cost of $67.19 per share, with a total value of $74,984.04. Following the completion of the purchase, the executive vice president owned 7,698 shares of the company’s stock, valued at approximately $517,228.62. The trade was a 16.96% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last 90 days, insiders acquired 5,843 shares of company stock worth $384,771. 2.16% of the stock is currently owned by corporate insiders.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.